INTERNATIONAL PATENT: ASCLETIS PHARMA (CHINA) CO., LIMITED FILES APPLICATION FOR "GLP-1RGIPRGCGR MODULATOR IN COMBINATION WITH THR-BETA MODULATOR FOR TREATMENT OF METABOLIC DISEASES"

GENEVA, May 10 -- ASCLETIS PHARMA (CHINA) CO., LIMITED (Room 1903, 19/F, Lee Garden One, 33 Hysan Avenue, Causeway Bay,Hong Kong) filed a patent application (PCT/CN2025/131228) for "GLP-1RGIPRGCGR MODULATOR IN COMBINATION WITH THR-BETA MODULATOR FOR TREATMENT OF METABOLIC DISEASES" on Oct 30, 2025. With publication no. WO/2026/092580, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WU, Jinzi Jason (Room 1903, 19/F, Lee Garden One, 33 Hysan Avenue, Causeway Bay,Hong Kong)

Abstract: Provided herein are method of thyroid ho...